Targacept, Inc. is a biopharmaceutical company engaged in the design, discovery and development of neuronal nicotinic receptors (NNR) Therapeutics for the treatment of multiple diseases and disorders of the central nervous system. The Company has clinical-stage product candidates for... more
CuraGen Corporation (CuraGen) is a biopharmaceutical development company engaged in developing therapeutics for the treatment of cancer. The Company is focused on advancing its cancer treatments, belinostat and CR011-vcMMAE, through clinical development and toward commercialization. In... more
GenVec, Inc. (GenVec) is a clinical stage biopharmaceutical company developing gene-based therapeutic drugs and vaccines. Its lead product candidate, TNFerade biologic (TNFerade), is being developed for use in the treatment of cancer. As of December 31, 2007, TNFerade was the subject of a... more
EntreMed, Inc. (EntreMed) is a clinical-stage pharmaceutical company focused on developing multi-mechanism oncology drugs that target disease cells and the blood vessels that nourish them. The Company focused on developing drugs that are safe and convenient, and provide the potential for... more
Sunesis Pharmaceuticals, Inc. (Sunesis) is a clinical-stage biopharmaceutical company. The Company focuses on the discovery, development and commercialization of small molecule therapeutics for use in oncology and other diseases. As of December 31, 2007, the Company was advancing three... more
Peregrine Pharmaceuticals, Inc. (Peregrine) is a biopharmaceutical company with a portfolio of clinical stage and pre-clinical product candidates using monoclonal antibodies for the treatment of cancer and viral diseases. The Company is advancing three separate clinical programs... more
Avalon Pharmaceuticals, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of first-in-class cancer therapeutics. Its lead product candidate, AVN944, an inosine monophosphate dehydrogenase (IMPDH) inhibitor, is in Phase II clinical development.... more
Arena Pharmaceuticals, Inc. (Arena) is a clinical-stage biopharmaceutical company focused on the discovering, developing and commercializing oral drugs in four therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases. The Company’s advanced drug... more
Demegen develops natural and novel peptides for the treatment or prevention of infections due to multi-drug resistant bacteria and fungi. The Company's lead products address important unmet medical needs. Applications under development include dermatological, vaginal, respiratory,... more
TOPIGEN is developing several new classes of drugs and is actively progressing two drug candidates in Phase II trials for COPD and asthma. These drugs are uniquely focused on inhibiting multiple inflammation targets underlying the chronic pulmonary diseases. TOPIGEN also has a number of... more
AlphaRx is developing several drug products in the therapeutic categories of Osteoarthritis and Infectious Disease. AlphaRx intends to file IND and NDA submissions with the FDA (when necessary) and license these products to other pharmaceutical companies for worldwide commercialization. ... more
Nastech Pharmaceutical Company Inc. is an emerging pharmaceutical company dedicated to the development and commercialization of unique products to treat diseases in areas where our innovations will have the greatest impact on improving human health.
Inhibitex, Inc. is a biopharmaceutical company focused on the development of differentiated anti-infective products. It pursues pre-clinical or clinical-stage antiviral development programs via in-licensing or acquisition. On September 19, 2007, the Company completed the acquisition of... more
Immusol is a private biotechnology company located in San Diego, California. The company currently employs approximately 50 employees, 90% of whom are focused on Research and Development. Immusol has built a management team with considerable combined experience in drug discovery and... more
TorreyPines Therapeutics, Inc. is a biopharmaceutical company committed to providing patients with alternatives to existing therapies through the research, development and commercialization of small molecule compounds. The Company seeks to develop versatile product candidates each capable... more
D-Pharm (www.dpharm.com) is a biopharmaceutical company pioneering the development of lipid-like therapeutics and has generated a rich product pipeline from its drug targeting and discovery technologies, Regulated Activation of Prodrugs (D-RAPTM) and Membrane Active Chelators (MAC). The... more
Athersys, Inc. is a biopharmaceutical company engaged in the discovery and development of therapeutic product candidates. In July 2007, the Company initiated a Phase I clinical trial in the United Kingdom with its lead candidate in clinical development, ATHX-105, for the treatment of... more
Corautus Genetics Inc. is a biopharmaceutical company dedicated to the development and commercialization of innovative gene therapy products for the treatment of cardiovascular and vascular disease. Corautus is currently developing and testing a gene therapy product using the Vascular... more
GlycoDesign is a drug discovery and development company focused on developing proprietary drugs for the treatment or prevention of cardiovascular and chronic inflammatory diseases, as well as cancer. The Company's resources are focused on two lead antithrombotic drug candidates, GH9001... more
Aphton Corporation, headquartered in Philadelphia, Pennsylvania is a clinical stage biopharmaceutical company focused on developing targeted immunotherapies for cancer and other diseases. The Company's products seek to neutralize hormones involved in the growth and proliferation of... more
Rexahn (www.rexahn.com) also raised $3.85 million through a private placement before becoming a public company. It bought New York-based Corporate Roadshow.com, a defunct Internet business, in May in a reverse merger that basically turned Rexahn into a public company. Investors in Rexahn... more
Protalix BioTherapeutics, Inc. is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its ProCellEx protein expression system. Using its ProCellEx system, the Company is developing a pipeline of recombinant therapeutic... more
Santaris Pharma is a pioneer in the field of oligonucleotide drugs based on the third generation RNA chemistry, Locked Nucleic Acid (LNA), to which the company holds worldwide exclusive rights in therapeutics. Amongst several unique features, the LNA chemistry enables the development of... more
BioXell S.p.A is an Italy-based biopharmaceutical company. The Company focuses on the research, development and commercialization of novel therapies for various medical needs. It is active in related therapeutic areas, such as urology (benign prostatic hyperplasia, overactive bladder and... more
Dynogen is a clinical stage biopharmaceutical company developing more effective treatments for gastrointestinal (GI) and genitourinary (GU) disorders. The Company has an advanced pipeline of clinical development programs focused on attractive and untapped markets in disease areas that... more
Mpex Pharmaceuticals is a clinical stage biopharmaceutical company whose mission is to develop important new therapies to combat the growing issue of antibiotic resistance. While much of the attention in the medical community has been focused on resistance in gram-positive pathogens such... more
Viron Therapeutics is a clinical stage biopharmaceutical company developing a completely new class of anti-inflammatory therapeutics to treat and prevent human inflammatory disorders. Viron's novel approach to drug development is based on the use of viral proteins as a source of... more
Ambrx, Inc. is a biopharmaceutical company with a mission to deliver breakthrough protein therapeutics. Ambrx is based on a fundamental advance in protein biosynthesis that enables the company to genetically engineer proteins with new amino acid building blocks beyond the common twenty,... more
Milkhaus, fortified by the numerous scientific patents it holds, is devoting itself to providing products designed to enhance urological health, skin care, wound care, and address other healthcare concerns.
Collgard Biopharmaceuticals, the tissue therapeutics company, is developing drug treatments that target disease progression by directly influencing the tissue regeneration process. Central to Collgard's novel approach is its lead drug candidate, Tempostatin (Halofuginone hydrobromide).... more
Bayhill Therapeutics Inc. is focused on the translation of research into therapeutics by developing novel drugs for the treatment of autoimmune diseases. The company has established a product platform of antigen-specific therapeutics, BHT-DNA, with broad potential applications in treating... more
Sequella is a clinical stage biopharmaceutical company focused on commercializing improved treatment paradigms for diseases of epidemic potential. The company leverages its global influence, R&D platforms and infectious disease expertise to proactively address emerging health threats.... more
Launched in December of 1996, Phytomedics is a privately owned Company that operates from its corporate headquarters in Jamesburg, NJ. Most of the Company's R&D takes place at the Biotech Center at Rutgers University, under the leadership of Dr. Ilya Raskin, a Company co-founder.... more
InteKrin Therapeutics, Inc. is a privately-held biopharmaceutical company based in Los Altos, CA pursuing the clinical development of therapeutics for diabetes, obesity and metabolic disorders. The company focuses on high value therapeutics addressing significant unmet medical needs in... more
Ascenta Therapeutics, Inc. is a clinical-stage biopharmaceutical company headquartered in San Diego, California, with a clinical trials management office in Malvern, Pennsylvania and a research and development subsidiary in Shanghai, China. Our company is dedicated to the discovery and... more
ReceptoPharm, Inc. maintains collaborative and research relationships with a number of noted academic researchers associated with the National Institutes of Health (NIH), Harvard University, Massachusetts General Hospital, Yale University, Stanford University, Baylor College of Medicine,... more
Cytheris is a privately held company founded in January 1999. In April 1999, the company signed an exclusive worldwide in-licensing agreement on the basic patents protecting Interleukin-7 (IL-7). In July 2002, we completed our B Series of venture financing for around EUR 7 millions... more
NovaCal Pharmaceuticals is a clinical-stage pharmaceutical company developing a new class of compounds: The AganocideÔ compounds. They are novel, safe and effective non-antibiotic antimicrobial molecules. Our goals are two-fold: 1) to reduce the threat of hospital-based infections, and 2)... more
Discovery Therapeutics, Inc., headquartered in Richmond, Virginia is a privately held, clinical-stage biopharmaceutical company focused on discovery, development and commercialization of products for the diagnosis and treatment of cardio-renal diseases. Discovery Therapeutics' product... more
NovaBay Pharnaceuticals, Inc. (NovaBay) is a clinical stage biopharmaceutical company focused on developing product candidates for the treatment or prevention of different infections in hospital and non-hospital environments. The Company has discovered and is developing a class of... more
 |
 |
 |
Products Overview | Add New Company | Add Your Profile | Tools & Resources | Developer API
FAQ | Privacy Policy | Terms of Service | About Us | Contact Us | Jobs at ZoomInfo | Advertise with Us
Copyright © 2008 Zoom Information Inc. All rights reserved.
BBeachHead-Oct08_RC001_P020.1 OM12
